@conference{6217fb7eddad46c4b8f814b8866d6e56,
title = "CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA",
author = "Yasmeen Rauf and David Peereboom and Jaleh Fallah and Cathy Schilero and Pamela Lackner and Glen Stevens and Manmeet Ahluwalia",
note = "AbstractBACKGROUND. Glioblastoma is a devastating disease that is notoriously resistant to current therapies, leading to dismal patient outcomes and a median su; Neuro-oncology ; Conference date: 09-11-2020",
year = "2020",
month = nov,
day = "9",
doi = "10.1093/NEUONC/NOAA215.154",
language = "American English",
}